{
|
"batch_id": "BATCH-STOCK-VALUATION-QINGFENGPU-TIMELINE-20260825-001",
|
"ticker": "300142.SZ",
|
"company": "沃森生物",
|
"as_of": "2026-08-25",
|
"v2_status": "BLOCKED",
|
"v2_failure": {
|
"complete": false,
|
"error": "ValueError: E_HISTORICAL_SHARES_UNPROVEN：quote f124 缺失或为 0",
|
"error_code": "E_CORE_INPUT",
|
"error_type": "CoreInputError",
|
"recorded_at": "2026-08-25T19:56:59.755+08:00",
|
"rollback_errors": [],
|
"run_id": "3d47817943d34ea3a608fd9bc7b896e3",
|
"schema_version": 2,
|
"status": "BLOCKED"
|
},
|
"v2_runtime_package": "v2_300142_SZ.failed-3d47817943d34ea3a608fd9bc7b896e3",
|
"v2_raw_artifact_hashes": [
|
"0a149c2f65b9c9a89bf77887a0271e9c8ba107fa6b838a275346396576359fea",
|
"1b7aeafb91a79d5f8337d3e94a6044d70ff197e9d4c0fe92067f432bcd5a1f3f",
|
"40c41316cdc28f72d310ddb6bba5a1b715f09919b6f79c69d5bfbdc347f1aa5d",
|
"43036926cdda0c75a0fee961d1a5b87445d9181d4078ee79ee49d5ef3a975dfb",
|
"66c560c8e467bd1e87d9804eafed1d309eed7d699cd5e09a2393ada0604ff228",
|
"75424abe7aefacbf87eba00de6e2311953f5ff8b4734c6c621113574d421e254",
|
"7564ae22af24873798ed9693be72824c873c533f9d1af6b5d1608fe7734dbd36",
|
"a02b976e06f4e4d6d4e1526a3085c830769a17fea2bbd665d08170014a1d11c0",
|
"ca819c277a81110892fa08d9cdbb409f48cbd7f307945e5f9982d3a40073c8bb",
|
"ea6528a2204b61a7ee34683a73ca00f8afdc86aadf3f765d4dae39bbfb19dbe7"
|
],
|
"market_contract": {
|
"table": "trading_xuntou.cn_stock_kline_1d_front",
|
"source": "xtquant",
|
"source_batch_id": "FKL_20260825_161021_6bd1f63d_1d_20260825_00006",
|
"updated_at": "2026-08-25 16:37:14",
|
"trade_date": "2026-08-25"
|
},
|
"quote_raw_hash": "43036926cdda0c75a0fee961d1a5b87445d9181d4078ee79ee49d5ef3a975dfb",
|
"share_proof": {
|
"shares": 1599348541.0,
|
"shares_fallback": false,
|
"shares_fallback_source": "eastmoney.market:f84",
|
"report_shares": 1599348541.0,
|
"share_unit_correction": null,
|
"static_total_shares": 1599348541.0,
|
"match_report": true,
|
"quote_market_cap": 23062605961.22,
|
"price_times_shares": 23062605961.22,
|
"gap_rate": 0.0
|
},
|
"industry_membership": {
|
"industries": [
|
"医药"
|
],
|
"layers": [
|
"reverse:医药、创新药与疫苗",
|
"timeline"
|
],
|
"research_name": "沃森生物"
|
},
|
"bounded_gaps": [
|
"V2 quote f124=0，端到端流程诚实阻断；正式估值用当前总股本/市值勾稽，股本历史日期无A1完全匹配时显式保留缺口。",
|
"机构汇总缺逐家报告日期与明细，不把一致预期写成法定事实。"
|
],
|
"checks": {
|
"v1_qa": {
|
"error_count": 0,
|
"info_count": 1,
|
"issues": [
|
{
|
"action": "补充法定披露、行情接口或机构预测汇总页来源。",
|
"field": "institutions",
|
"issue_id": "QA-CORE-SOURCE-MISSING",
|
"message": "核心字段没有由注册表中允许承载核心数字的来源支持。",
|
"recalc_scope": "institutions",
|
"severity": "WARNING"
|
},
|
{
|
"action": "拆解营运资本、资本开支与回款持续性。",
|
"field": "metrics.annual_fcf",
|
"issue_id": "QA-NEGATIVE-FCF",
|
"message": "最近完整年度简化自由现金流为负。",
|
"recalc_scope": "DCF 与现金流交叉验证",
|
"severity": "WARNING"
|
},
|
{
|
"action": "不得以公司业绩预告或自有情景冒充机构预期。",
|
"field": "institutions",
|
"issue_id": "QA-INSTITUTION-NONE",
|
"message": "估值日没有可用机构盈利预测，已明确记录为空。",
|
"recalc_scope": "机构预期模块",
|
"severity": "INFO"
|
}
|
],
|
"status": "PASS_WITH_WARNINGS",
|
"warning_count": 2
|
},
|
"label": "明显偏贵",
|
"base_low": 2.1103703269211285,
|
"base_high": 5.172476291473355,
|
"optimistic_high": 9.99322419512652,
|
"price": 14.42,
|
"bubble_status": "泡沫-极端"
|
}
|
}
|
